A cautionary note on the selectivity of oncolytic poxviruses

Bingtao Tang,David L Bartlett,Edward J Roy,Grant McFadden,Jia Liu,Joanna L Shisler,Zong Sheng Guo

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]

Directed evolution as a tool for the selection of oncolytic RNA viruses with desired phenotypes

Galina V Kochneva,Olga V Matveeva,Peter M Chumakov,Sergei S Zainutdinov,Sergei V Netesov

Oncolytic virus and PD-1/PD-L1 blockade combination therapy

Brian Hutzen,Chun-Yu Chen,Mary F Wedekind,Timothy P Cripe

Current understanding of reovirus oncolysis mechanisms

Bernardo A Mainou,Jameson TL Berry,Johnasha D Stuart,Karl W Boehme,Matthew B Phillips,Roxana M Rodríguez Stewart

Oncolytic myxoma virus synergizes with standard of care for treatment of glioblastoma multiforme

Arabinda Das,Chase Burton,Daniel McDonald,David Cachia,Eric Bartee,Sunil J Patel,William A Vandergrift, III

Oral poliovirus vaccine-induced programmed cell death involves both intrinsic and extrinsic pathways in human colorectal cancer cells

Abdolvahab Moradi,Alijan Tabarraei,Marie Saghaeian Jazi,Mohamad Reza Kalani,Mohsen Saeidi,Sareh Zhand,Seyed Masoud Hosseini

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer

Catherine M Crosby,Gregory J Heller,Mary E Barry,Michael A Barry,Tien V Nguyen,Zachary I Mendel

Proof-of-principle that a decoy virus protects oncolytic measles virus against neutralizing antibodies

Annika Verena Go？,Carmen Dorneburg,Christian Beltinger,Chun Xu,Jiwu Wei,Klaus-Michael Debatin

Development and applications of oncolytic Maraba virus vaccines

Brian D Lichty,Byram W Bridle,Caroline J Breitbach,Chantal G Martin,David F Stojdl,Fabrice Le Boeuf,Jean-Simon Diallo,Jeff L Hummel,John C Bell,Jonathan G Pol,Julia Pomoransky,Kyle B Stephenson,Matthew J Atherton,Yonghong Wan

Three-dimensional tumor cell cultures employed in virotherapy research

Can Yurttas,Linus D Kloker,Ulrich M Lauer

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect

Bolni M Nagalo,Brent Vernon,Dan G Duda,Hassan Albadawi,Jan B Egan,Mitesh J Borad,Rahmi Oklu,Raquel Yokoda,Thomas T DeLeon,Yumei Zhou

Editorial announcing PubMed indexing of Oncolytic Virotherapy

Faris Farassati

Potential of oncolytic viruses in the treatment of multiple myeloma

Eric Bartee

Proinflammatory response induced by Newcastle disease virus in tumor and normal cells

George Mathew,Jeremiah Suryatenggara,Salomo Christian,Teridah Ernala Ginting

Novel oncolytic viral therapies in patients with thoracic malignancies

Robert A Kratzke,Zeeshan Ahmad

Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma

Hani M Babiker,Irbaz Bin Riaz,Mitesh J Borad,Muhammad Husnain

The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses

Adrian Pelin,Fabrice Le Boeuf,Jiahu Wang,John Bell

Oncolytic virotherapy in upper gastrointestinal tract cancers

Bolni M Nagalo,Daniel H Ahn,James M Bogenberger,Jan B Egan,Mansi Arora,Mitesh J Borad,Raquel Yokoda,Thomas T DeLeon,Yumei Zhou

Curative effect of HF10 on liver and peritoneal metastasis mediated by host antitumor immunity

Hideki Kasuya,Itzel Bustos,Maki Tanaka,Toru Ichinose,Yasuhiro Kodera,Yoshihiro Hotta,Yoshinori Naoe

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances

Alan Melcher,Guy R Simpson,Hardev Pandha,Kate Relph,Kevin Harrington

Thyroid malignant neoplasm-associated biomarkers as targets for oncolytic virotherapy

Gaetano Romano,Mingxu Guan,Sahil Rajesh Shah,Yanping Ma

Oncolytic adenovirus-mediated therapy for prostate cancer

Gunnel Halldén,Katrina Sweeney

Oncolytic Seneca Valley Virus: past perspectives and future directions

Michael J Burke

High-throughput screening to enhance oncolytic virus immunotherapy

David F Stojdl,KJ Allan,SL Swift

Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes

Marlana Orloff

Oncolytic virotherapy for pediatric malignancies: future prospects

Alicia M Waters,Elizabeth A Beierle,Eric K Ring,Gregory K Friedman

Myxoma virus therapy for human embryonal rhabdomyosarcoma in a nude mouse model

Amy L MacNeill,Valerie A Hilgenberg,Veronica G Kinn

Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy

Ahmed Majeed Al-Shammari,Huda Rameez,Maha F Al-Taee

CXCL12 retargeting of an adenovirus vector to cancer cells using a bispecific adapter

Angel A Rivera,David T Curiel,J Michael Mathis,Samia M O’Bryan,Shilpa Bhatia